Literature DB >> 6266565

The binding of [3H]-prostacyclin to membranes of a neuronal somatic hybrid.

I A Blair, J MacDermot.   

Abstract

1 [3H]-prostacyclin bound to a washed membrane preparation of the NCB-20 neuronal hybrid cell line. 2 Kinetic analysis of [3H]-prostacyclin binding suggested a simple, non-cooperative bimolecular interaction between the ligand and a single receptor population. The equilibrium dissociation constant was 16.6 nM, and binding at a saturating [3H]-prostacyclin concentration enabled the receptor density of 2.57 x 10(5) receptor molecules per cell to be calculated. 3 At 20 degrees C the rate constant for the forward reaction (K+1) was 2.26 x 10(5) M-1 S-1, and the rate constant for the dissociation of the ligand-receptor complex (k-1) was 3.85 x 10(-3) S-1. Thus the dissociation constant (k-1/k+1) was 17.0 nM. 4 Prostaglandin E1 and prostacyclin compete for a single receptor in these cells, and comparison of other prostaglandins as inhibitors of [3H]-prostacyclin binding revealed some of the structural requirements for high-affinity occupation of prostacyclin receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6266565      PMCID: PMC2071583          DOI: 10.1111/j.1476-5381.1981.tb10994.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Morphine receptors as regulators of adenylate cyclase activity.

Authors:  S K Sharma; M Nirenberg; W A Klee
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  The role of GTP in the activation of adenylate cyclase.

Authors:  A Levitzki
Journal:  Biochem Biophys Res Commun       Date:  1977-02-07       Impact factor: 3.575

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Binding of (3H)prostaglandin E1 to putative receptors linked to adenylate cyclase of cultured cell clones.

Authors:  L L Brunton; R A Wiklund; P M Van Arsdale; A G Gilman
Journal:  J Biol Chem       Date:  1976-05-25       Impact factor: 5.157

5.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

6.  Prostacyclin-dependent activation of adenylate cyclase in a neuronal somatic cell hybrid: prostanoid structure-activity relationships.

Authors:  I A Blair; C N Hensby; J MacDermot
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

7.  The chemical structure of prostaglandin X (prostacyclin).

Authors:  N Whittaker; S Bunting; J Salmon; S Moncada; J R Vane; R A Johnson; D R Morton; J H Kinner; R R Gorman; J C McGuire; F F Sun
Journal:  Prostaglandins       Date:  1976-12

8.  Expression of phenotypes in hybrid somatic cells derived from the nervous system.

Authors:  J D Minna; J Yavelow; H G Coon
Journal:  Genetics       Date:  1975-06       Impact factor: 4.562

9.  Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.

Authors:  J E Tateson; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1977-03

10.  Properties of opiate-receptor binding in rat brain.

Authors:  C B Pert; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

View more
  13 in total

1.  The role of PGE2 in the sensitization of mechanoreceptors in normal and inflamed ankle joints of the rat.

Authors:  B D Grubb; G J Birrell; D S McQueen; A Iggo
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Proceedings of the British Pharmacological Society, University of Cambridge, 6th-8th April, 1983. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

3.  Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.

Authors:  R A Armstrong; R L Jones; J MacDermot; N H Wilson
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

4.  Prostanoid receptors involved in the relaxation of human bronchial preparations.

Authors:  X Norel; L Walch; C Labat; J P Gascard; E Dulmet; C Brink
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Prostanoid receptors involved in the relaxation of human pulmonary vessels.

Authors:  L Walch; C Labat; J P Gascard; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.

Authors:  J E Merritt; T J Hallam; A M Brown; I Boyfield; D G Cooper; D M Hickey; A A Jaxa-Chamiec; A J Kaumann; M Keen; E Kelly
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

7.  Desensitization of prostacyclin receptors in a neuronal hybrid cell line.

Authors:  I A Blair; P J Leigh; J MacDermot
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

8.  The action of prostaglandins on ion channels.

Authors:  Hans Meves
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

9.  Activation of mechanonociceptors by pro-inflammatory peptides melittin and PLAP peptide.

Authors:  B Cooper; J S Bomalaski
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

10.  Divalent cations increase [3H]-prostacyclin binding to membranes of neuronal somatic hybrid cells.

Authors:  I A Blair; T M Cresp; J MacDermot
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.